XFOR Collar Strategy
XFOR (X4 Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
X4 Pharmaceuticals, Inc. is a biopharmaceutical firm committed to the discovery, development, and commercialization of innovative therapies for uncommon immune system disorders. Its primary drug candidate, XOLREMDI (also known as mavorixafor), is an orally administered, small-molecule antagonist specifically designed to target the chemokine receptor CXCR4. This compound is currently undergoing Phase 3 clinical trials for the management of WHIM syndrome, a rare immunodeficiency characterized by symptoms such as warts, hypogammaglobulinemia, recurrent infections, and myelokathexis. To broaden its global presence, the company has entered into several licensing agreements: A partnership with Abbisko Therapeutics Co Ltd. grants rights for the manufacturing and distribution of XOLREMDI in mainland China, Taiwan, Hong Kong, and Macau. Another agreement with Norgine covers the development, production, and commercialization of mavorixafor across Europe, Australia, and New Zealand. Furthermore, X4 Pharmaceuticals holds a comprehensive agreement with Genzyme Corporation concerning the CXCR4 receptor, allowing for the development and commercialization of licensed compounds for all medical applications, including therapeutic, preventive, and diagnostic uses.
XFOR (X4 Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $404.6M, a beta of 0.35 versus the broader market, a 52-week range of 2.45-4.83, average daily share volume of 598K, a public-listing history dating back to 2017, approximately 45 full-time employees. These structural characteristics shape how XFOR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.35 indicates XFOR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a collar on XFOR?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
XFOR snapshot
As of August 14, 2026, spot at $4.20, ATM IV 358.60%, IV rank 74.65%, expected move 102.81%. The collar on XFOR below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this collar structure on XFOR specifically: IV regime affects collar pricing on both sides; elevated XFOR IV at 358.60% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 102.81% (roughly $4.32 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated XFOR expiries trade a higher absolute premium for lower per-day decay. Position sizing on XFOR should anchor to the underlying notional of $4.20 per share and to the trader's directional view on XFOR stock.
XFOR collar setup
The XFOR collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With XFOR at $4.20 on that close, the first option leg uses a $4.41 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed XFOR chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 XFOR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $4.20 | long |
| Sell 1 | Call | $4.41 | N/A |
| Buy 1 | Put | $3.99 | N/A |
XFOR collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
XFOR collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on XFOR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on XFOR
Collars on XFOR hedge an existing long XFOR stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
XFOR thesis for this collar
The market-implied 1-standard-deviation range for XFOR extends from approximately $-0.12 on the downside to $8.52 on the upside. A XFOR collar hedges an existing long XFOR position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current XFOR IV rank near 74.65% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on XFOR at 358.60%. As a Healthcare name, XFOR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to XFOR-specific events.
XFOR collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. XFOR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move XFOR alongside the broader basket even when XFOR-specific fundamentals are unchanged. Always rebuild the position from current XFOR chain quotes before placing a trade.
Frequently asked questions
- What is a collar on XFOR?
- A collar on XFOR is the collar strategy applied to XFOR (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With XFOR stock at $4.20 on the most recent close, the strikes shown on this page are snapped to the nearest listed XFOR chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are XFOR collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the XFOR collar priced from the end-of-day chain at a 30-day expiry (ATM IV 358.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a XFOR collar?
- The breakeven for the XFOR collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The XFOR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 102.81%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on XFOR?
- Collars on XFOR hedge an existing long XFOR stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current XFOR implied volatility affect this collar?
- XFOR ATM IV is at 358.60% with IV rank near 74.65%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.